Your browser doesn't support javascript.
loading
Facial redness in Japanese adolescents with atopic dermatitis treated with dupilumab: A case series.
Hara, Shuhei; Itonaga, Takaaki; Nishino, Makoto; Yanagida, Noriyuki; Sato, Sakura; Ebisawa, Motohiro.
Afiliação
  • Hara S; Department of Pediatrics and, Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, Sagamihara, Japan.
  • Itonaga T; Department of Pediatrics and, Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, Sagamihara, Japan.
  • Nishino M; Department of Allergy, Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, Sagamihara, Japan.
  • Yanagida N; Department of Pediatrics and, Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, Sagamihara, Japan.
  • Sato S; Department of Allergy, Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, Sagamihara, Japan.
  • Ebisawa M; Department of Pediatrics and, Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, Sagamihara, Japan.
J Allergy Clin Immunol Glob ; 2(2): 100096, 2023 May.
Article em En | MEDLINE | ID: mdl-37780793
This case series study is the first report of Japanese adolescents who experienced dupilumab facial redness after starting dupilumab treatment for refractory atopic dermatitis. In every case, dupilumab facial redness subsided without discontinuation of dupilumab within 3 months after onset.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: J Allergy Clin Immunol Glob Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Japão

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: J Allergy Clin Immunol Glob Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Japão
...